Science Corporation’s brain tech is worth $3.5 billion after new funding

Science Corporation, a medical tech startup founded by former Neuralink president Max Hodak, has raised $400 million in Series D funding. The company is developing brain-computer interface technology and vision-restoring implants.
Why it matters
Advances in neurotechnology and brain-computer interfaces represent a major frontier in medical science with potential to treat previously incurable conditions.
Science Corporation , the medical technology start-up founded by former Neuralink president Max Hodak in 2021, raised a $400 million Series D, the company said in a blog post .
Investors in the new round valued the company at $3.5 billion, a person familiar with the deal told TechCrunch. Those backers included Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech.
Hodak, who talked his way into a graduate neuroscience lab as a college student and has pursued biotechnology ever since, co-founded Science to leverage new technologies to understand and interact with the brain.
Science’s first product is PRIMA, a wearable and implantable chip that helps people with age-related macular degeneration recover some vision. The device is approved in Europe and available in Germany, as well as being trialled for new conditions.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in